VIVE - ビビ―ブ・メディカル （Viveve Medical Inc.） ビビ―ブ・メディカルVIVEのチャート
VIVEの企業情報
| symbol | VIVE |
|---|---|
| 会社名 | Viveve Medical Inc （ビビ―ブ・メディカル） |
| 分野（sector） | Health Care ヘルスケア |
| 産業（industry） | Biotechnology: Electromedical_Electrotherapeutic Apparatus |
| 業種 | 先端医療機器_テクノロジ― 医療関連（Health Care） |
| 概要 | 事業概要 ビビーブ・メディカル(Viveve Medical Inc.)は膣若返り及び膣の弛緩向けの非侵襲的治療用Geneveveという医療機器を設計、開発、製造、販売する。同社のGeneveveは、無線周波数（RF）、テーブルトップコンソールに収納されたジェネレータであるViveveシステム、再使用可能なハンドピースと使い捨て治療チップ及び他の消耗品アクセサリーという3つのコンポーネントを含む膣の弛緩向け非侵襲的ソリューションである。医師は使い捨て治療チップをコンソールに接続されたハンドピースに取り付ける。ジェネレータは治療チップを認証し、医師の介入なしに所望の治療のためにシステムをプログラムする。治療は医師のオフィスで30分以内に行われ、麻酔を使用する必要がない。Geneveveは米国での電気凝固及び止血向けの一般的外科的処置に使用される。 ビビ―ブ・メディカルは米国の医療機器メ―カ―。主に女性特有の健康問題を中心に、電子医療機器の開発・製造・販売に従事する。同社の「Viveve System」は特許取得済みで、高周波数技術を使用し女性の膣のゆるみを非侵襲性の処置により引き締め治療をする医療機器である。本社はカリフォルニア州サニ―ベ―ル。 Viveve Medical, Inc. is a medical technology company focused on women's intimate health. Viveve is committed to advancing new solutions to improve women's overall well-being and quality of life. The internationally patented Viveve® System incorporates Cryogen-cooled Monopolar Radiofrequency technology to uniformly deliver volumetric heating while gently cooling surface tissue to generate neocollagenesis in a single in-office session. In the United States, the Viveve® System is cleared by the Food and Drug Administration (FDA) for use in general surgical procedures for electrocoagulation and hemostasis. International regulatory approvals and clearances have been received for vaginal laxity and/or improvement in sexual function indications in more than 50 countries. |
| 本社所在地 | 345 Inverness Drive South Building B Suite 250 Englewood CO 80112 USA |
| 代表者氏名 | James G. Atkinson ジェームズ・アトキンソン |
| 代表者役職名 | Chief Business Officer and President |
| 電話番号 | +1 408-530-1900 |
| 設立年月日 | 31837 |
| 市場名 | NASDAQ Small Cap |
| ipoyear | ―年 |
| 従業員数 | 103人 |
| url | www.viveve.com |
| nasdaq_url | https://www.nasdaq.com/symbol/vive |
| adr_tso | ― |
| EBITDA | EBITDA（百万ドル） -39.29100 |
| 終値（lastsale） | 3.02 |
| 時価総額（marketcap） | 95095288.12 |
| 時価総額 | 時価総額（百万ドル） 98.24414 |
| 売上高 | 売上高（百万ドル） 18.39500 |
| 企業価値(EV) | 企業価値(EV)（百万ドル） 97.75514 |
| 当期純利益 | 当期純利益（百万ドル） -44.02400 |
| 決算概要 | 決算概要 BRIEF: For the six months ended 30 June 2018 Viveve Medical Inc revenues increased 51% to $9.2M. Net loss increased 41% to $24.2M. Revenues reflect North America segment increase of 38% to $2.6M Asia Pacific (Region) segment increase of 20% to $891K. Higher net loss reflects Selling general and administrative - Ba increase of 47% to $17.1M (expense) Research and development - Balancing val increase of 16% to $6.6M (expense). |
VIVEのテクニカル分析
VIVEのニュース
Viveve Medical, Inc. (VIVE) Q3 2022 Earnings Call Transcript 2022/11/11 02:25:04 Seeking Alpha
Viveve Medical, Inc. (NASDAQ:NASDAQ:VIVE) Q3 2022 Results Conference Call November 10, 2022 05:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications…
Viveve Medical GAAP EPS of -$0.59 beats by $0.07, revenue of $17M beats by $15.29M 2022/11/10 21:44:07 Seeking Alpha
Viveve Medical press release (VIVE): Q3 GAAP EPS of -$0.59 beats by $0.07.Revenue of $17M (+962.5% Y/Y) beats by $15.29M.Gross profit for the third quarter of 2022 was $0.5 million,…
Viveve Medical, Inc.: Viveve Reports Third Quarter 2022 Financial Results and Provides Corporate Update 2022/11/10 21:08:00 Finanz Nachrichten
Total revenue of $1.7 million in Q3 including sale of 3,100 disposable treatment tipsPURSUIT clinical trial completion expected by year-endConference call to be hosted by Company at 5:00 PM ET toda…
Viveve Medical Q3 2022 Earnings Preview 2022/11/09 19:20:04 Seeking Alpha
Viveve Medical (VIVE) is scheduled to announce Q3 earnings results on Thursday, November 10th, after market close.The consensus EPS Estimate is -$0.66 and the consensus Revenue Estimate is…
Viveve Medical, Inc.: Viveve to Report Third Quarter 2022 Financial Results and Provide Corporate Update on November 10, 2022 2022/10/27 12:32:00 Finanz Nachrichten
ENGLEWOOD, CO / ACCESSWIRE / October 27, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s health and the treatment of stress urinary incontinence (SUI), to…
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript 2022/05/13 01:06:01 Seeking Alpha
Viveve Medical, Inc. (NASDAQ:NASDAQ:VIVE) Q1 2022 Earnings Conference Call May 12, 2022 05:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim…
Viveve Medical GAAP EPS of -$0.67 beats by $0.01, revenue of $1.64M beats by $0.03M 2022/05/12 21:00:12 Seeking Alpha
Viveve Medical press release (VIVE): Q1 GAAP EPS of -$0.67 beats by $0.01.Revenue of $1.64M (+13.1% Y/Y) beats by $0.03M.Increased the installed base of Viveve Systems to 895…
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update 2022/05/12 20:01:00 Viveve Medical
ENGLEWOOD, CO / ACCESSWIRE / May 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today.
Viveve Medical Q1 2022 Earnings Preview (NASDAQ:VIVE) 2022/05/11 21:35:39 Seeking Alpha
Viveve Medical (VIVE) is scheduled to announce Q1 earnings results on Thursday, May 12th, after market close.The consensus EPS Estimate is -$0.68 and the consensus Revenue Estimate…
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022 - Stocks News Feed 2022/04/28 12:43:48 Stocks News Feed
ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 12, 2022. The Company will… Read More »Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022
Viveve Medical, Inc. (VIVE) CEO Scott Durbin on Q1 2022 Results - Earnings Call Transcript 2022/05/13 01:06:01 Seeking Alpha
Viveve Medical, Inc. (NASDAQ:NASDAQ:VIVE) Q1 2022 Earnings Conference Call May 12, 2022 05:00 PM ET Company Participants Jeannie Swindle - Senior Director, Corporate Communications Jim…
Viveve Medical GAAP EPS of -$0.67 beats by $0.01, revenue of $1.64M beats by $0.03M 2022/05/12 21:00:12 Seeking Alpha
Viveve Medical press release (VIVE): Q1 GAAP EPS of -$0.67 beats by $0.01.Revenue of $1.64M (+13.1% Y/Y) beats by $0.03M.Increased the installed base of Viveve Systems to 895…
Viveve Reports First Quarter 2022 Financial Results and Provides Corporate Update 2022/05/12 20:01:00 Viveve Medical
ENGLEWOOD, CO / ACCESSWIRE / May 12, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women''s intimate health, today reported financial results for the quarter ended March 31, 2022, and will provide a corporate update on its scheduled conference call at 5:00 PM ET today.
Viveve Medical Q1 2022 Earnings Preview (NASDAQ:VIVE) 2022/05/11 21:35:39 Seeking Alpha
Viveve Medical (VIVE) is scheduled to announce Q1 earnings results on Thursday, May 12th, after market close.The consensus EPS Estimate is -$0.68 and the consensus Revenue Estimate…
Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022 - Stocks News Feed 2022/04/28 12:43:48 Stocks News Feed
ENGLEWOOD, CO / ACCESSWIRE / April 28, 2022 / Viveve Medical, Inc. (NASDAQ:VIVE), a medical technology company focused on women’s intimate health, today announced that it will report its first quarter 2022 financial results and provide a corporate update after the close of the U.S. financial markets on Thursday, May 12, 2022. The Company will… Read More »Viveve to Report First Quarter 2022 Financial Results and Provide Corporate Update on May 12, 2022